posted on 2023-12-01, 22:40authored byMausam Kalita, Jun Hyung Park, Renesmee Chenting Kuo, Samira Hayee, Sara Marsango, Valentina Straniero, Israt S. Alam, Angelie Rivera-Rodriguez, Mallesh Pandrala, Mackenzie L. Carlson, Samantha T. Reyes, Isaac M. Jackson, Lorenzo Suigo, Audrey Luo, Sydney C. Nagy, Ermanno Valoti, Graeme Milligan, Frezghi Habte, Bin Shen, Michelle L. James
Chronic innate immune activation is a key hallmark of many neurological
diseases and is known to result in the upregulation of GPR84 in myeloid
cells (macrophages, microglia, and monocytes). As such, GPR84 can
potentially serve as a sensor of proinflammatory innate immune responses.
To assess the utility of GPR84 as an imaging biomarker, we synthesized <sup><b>11</b></sup><b>C-MGX-10S</b> and <sup><b>11</b></sup><b>C-MGX-11S</b> <i>via</i> carbon-11 alkylation
for use as positron emission tomography (PET) tracers targeting this
receptor. <i>In vitro</i> experiments demonstrated significantly
higher binding of both radiotracers to hGPR84-HEK293 cells than that
of parental control HEK293 cells. Co-incubation with the GPR84 antagonist
GLPG1205 reduced the binding of both radiotracers by >90%, demonstrating
their high specificity for GPR84 <i>in vitro</i>. <i>In vivo</i> assessment of each radiotracer <i>via</i> PET imaging of healthy mice illustrated the superior brain uptake
and pharmacokinetics of <sup><b>11</b></sup><b>C-MGX-10S</b> compared to <sup><b>11</b></sup><b>C-MGX-11S</b>. Subsequent
use of <sup><b>11</b></sup><b>C-MGX-10S</b> to image a
well-established mouse model of systemic and neuro-inflammation revealed
a high PET signal in affected tissues, including the brain, liver,
lung, and spleen. <i>In vivo</i> specificity of <sup><b>11</b></sup><b>C-MGX-10S</b> for GPR84 was confirmed by
the administration of GLPG1205 followed by radiotracer injection.
When compared with <sup>11</sup>C-DPA-713an existing radiotracer
used to image innate immune activation in clinical research studies<sup><b>11</b></sup><b>C-MGX-10S</b> has multiple advantages,
including its higher binding signal in inflamed tissues in the CNS
and periphery and low background signal in healthy saline-treated
subjects. The pronounced uptake of <sup><b>11</b></sup><b>C-MGX-10S</b> during inflammation, its high specificity for GPR84,
and suitable pharmacokinetics strongly support further investigation
of <sup><b>11</b></sup><b>C-MGX-10S</b> for imaging GPR84-positive
myeloid cells associated with innate immune activation in animal models
of inflammatory diseases and human neuropathology.